Genmab AS

Genmab AS Accounts Payable

The Accounts Payable of Genmab AS (GMAB) as of Nov 22, 2026 is 1.07 B USD. In the previous year, Accounts Payable was 2.31 B USD — a change of -53.77% (lower).

Accounts Payable

1.07 BUSD

YoY

-53.77%

Last updated:

Accounts Payable of Genmab AS is 2025 1.07 B USD. Accounts Payable of Genmab AS was 2024 2.31 B USD. It decreases by -53.77% lower compared to the previous year.

The Genmab AS Accounts Payable history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Accounts Payable
Date
Accounts Payable
Jan 1, 2017
579.00 M USD
Jan 1, 2018
1.33 B USD
Jan 1, 2019
2.99 B USD
Jan 1, 2020
145.00 M USD
Jan 1, 2021
350.00 M USD
Jan 1, 2022
1.72 B USD
Jan 1, 2023
2.31 B USD
Jan 1, 2025
1.07 B USD
The Genmab AS Accounts Payable history
YEARAccounts PayableYoY
1.07 BUSD-53.77%
2.31 BUSD+34.44%
1.72 BUSD+390.29%
350.00 MUSD+141.38%
145.00 MUSD-95.15%
2.99 BUSD+125.32%
1.33 BUSD+129.19%
579.00 MUSD+2,499.80%
22.27 MUSD-30.38%
31.99 MUSD-69.78%
105.84 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Genmab AS Stock analysis

What does Genmab AS do? Genmab AS is a biotechnology company based in Copenhagen, Denmark, operating in the Health Care sector. It develops and markets antibody-based therapies for cancer and other diseases, including EPKINLY, TEPKINLY, and Tivdak for various lymphomas and cervical cancer. The company also advances several product candidates in clinical development, such as Epcoritamab for lymphomas and GEN1059 for solid tumors, alongside established treatments like DARZALEX and TECVAYLI for multiple myeloma and other conditions. Genmab AS is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genmab AS stock

Accounts Payable of Genmab AS is 1.07 B USD in 2025.

Accounts Payable of Genmab AS changed from 2.31 B USD to 1.07 B USD, representing a -53.77% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Accounts Payable Genmab AS since 2006 – with annual values, charts, and detailed analysis.

Accounts payable represents money owed to suppliers for goods and services received. It is a key component of working capital management.

Accounts Payable's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Accounts Payable's Genmab AS historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Genmab AS

All Key Metrics — Genmab AS